Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SCHMIDT ERIC THOMAS Create: Alert

All | News | Filings
Date FiledTypeDescription
06/12/2023 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 5,200 shares @ $0
Granted 18,400 options to buy @ $24.84, valued at $457.1k
05/30/2023 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 92,958 options to buy @ $3.37, valued at $313.3k
03/24/2023 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 558,094 shares @ $0
Granted 432,738 options to buy @ $5.04, valued at $2.2M
03/16/2023 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Paid exercise price by delivering 35,879 shares @ $5.47, valued at $196.3k
12/20/2022 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Granted 57,042 options to buy @ $3.37, valued at $192.2k
06/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/25/2022 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 237,358 shares @ $0
Granted 368,589 options to buy @ $9.69, valued at $3.6M
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 4,634 shares @ $32.6, valued at $151.1k
Sold 10,366 shares @ $33, valued at $342.1k
10/16/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 5,104 shares @ $39.4674, valued at $201.4k
Sold 4,218 shares @ $40.0689, valued at $169k
Sold 3,479 shares @ $41.3336, valued at $143.8k
Sold 2,099 shares @ $42.3247, valued at $88.8k
Sold 100 shares @ $43.01, valued at $4.3k
09/22/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 9,889 shares @ $34.755, valued at $343.7k
Sold 3,200 shares @ $35.9591, valued at $115.1k
Sold 1,911 shares @ $37.04, valued at $70.8k
06/19/2020 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on Revolution Medicines, Inc.
Txns: Granted 7,234 shares @ $0
Granted 25,318 options to buy @ $36.57, valued at $925.9k
06/19/2020 3 SCHMIDT ERIC THOMAS (Director) has filed a Form 3 on Revolution Medicines, Inc.
04/09/2020 4 SCHMIDT ERIC THOMAS (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.
Txns: Exercised (in-or-at-the-money) 32,500 options to buy @ $6, valued at $195k
Exercised (in-or-at-the-money) 12,500 options to buy @ $9, valued at $112.5k
03/20/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 30,800 shares @ $0
Granted 109,600 options to buy @ $18.22, valued at $2M
03/18/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Sold 5,150 shares @ $19.6957, valued at $101.4k
Sold 300 shares @ $20.25, valued at $6.1k
02/24/2020 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Disposed of 237,155 shares @ $25.3, valued at $6M
12/23/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
03/15/2019 4 SCHMIDT ERIC THOMAS (CFO) has filed a Form 4 on Allogene Therapeutics, Inc.
Txns: Granted 49,400 shares @ $0
Granted 83,500 options to buy @ $26.89, valued at $2.2M
10/10/2018 3 Form 3 - Initial statement of beneficial ownership of securities:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy